Stock listing
Viridian Therapeutics, Inc.
Selected listing: 1S1 · SWB · EUR · DE
Viridian Therapeutics, Inc. (Stuttgart:1S1), Health Technology. Latest release Aug 6, 2026: Viridian Therapeutics Highlights Recent Business Progress…
- Ticker
- Stuttgart:1S1
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Stuttgart
- Currency
- EUR
About Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. (VRDN) is a publicly traded company based in the United States, specializing in innovative therapies. The company is committed to advancing its research and development efforts to improve patient outcomes.
Latest news from Viridian Therapeutics, Inc.
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
August 6, 2026
Raymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)
July 16, 2026
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
June 26, 2026
Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
May 6, 2026
Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease
May 5, 2026
Events
Research Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. company profile
View the public company page for Viridian Therapeutics, Inc. on 6ix.
Viridian Therapeutics, Inc. news
Read company news and market updates connected to Viridian Therapeutics, Inc..
Viridian Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Viridian Therapeutics, Inc..
Alternate listings
VRDN:NASDAQ
US · USD
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
1S1:GETTEX
DE · EUR
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
A2QMUH:LSX
DE · EUR
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
A2QMUH:LS
DE · EUR
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
0K1R:LSE
GB · USD
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
1S1:TRADEGATE
DE · EUR
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
VRDN:BOATS
US · USD
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
1S1:FWB
DE · EUR
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.
1S1:DUS
DE · EUR
Alternate listing for Viridian Therapeutics, Inc.; the primary context on this page is 1S1:SWB.